Development Of Effective Transmission-Blocking Vaccine Could Prevent Spread Of Malaria

Thomson Reuters Foundation: To eliminate malaria it’s vital we vaccinate … mosquitoes?
Will Stone, researcher at the London School of Hygiene & Tropical Medicine

“…[W]hat if we could flip the malaria control paradigm: what if a vaccine could prevent mosquitoes getting malaria from humans? … [W]e are now better able to understand which people contribute to the spread of malaria. For a number of proteins, we are now investigating whether they could have potential as a transmission-blocking malaria vaccine. If they work in the lab, the major challenge for vaccinologists will be making the vaccine adequately powerful and long lasting to reduce malaria transmission in human populations. Ultimately it’s not one approach that will end malaria. However a transmission-blocking vaccine, combined with effective drugs, mosquito control, and a vaccine like RTS’S [(the world’s first malaria vaccine)], could prevent its spread and bring eradication of this deadly disease one step closer” (2/8).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.